Total Debt
$39.1M
Net Debt
-$627.2M
Monte Rosa Therapeutics, Inc. currently has $39.1M in total debt. Net debt is -$627.2M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
GLUE • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.04 | 0.67 | -0.63Net Cash | 0.74 | 5.3% |
| 2025-12-31 | 0.04 | 0.38 | -0.34Net Cash | 0.45 | 8.7% |
| 2025-09-30 | 0.04 | 0.39 | -0.35Net Cash | 0.46 | 8.7% |
| 2025-06-30 | 0.04 | 0.29 | -0.25Net Cash | 0.36 | 11.4% |
| 2025-03-31 | 0.04 | 0.33 | -0.28Net Cash | 0.39 | 10.6% |
| 2024-12-31 | 0.04 | 0.37 | -0.33Net Cash | 0.44 | 9.7% |
| 2024-09-30 | 0.04 | 0.24 | -0.20Net Cash | 0.32 | 13.9% |
| 2024-06-30 | 0.04 | 0.26 | -0.22Net Cash | 0.34 | 12.9% |
| 2024-03-31 | 0.05 | 0.19 | -0.15Net Cash | 0.27 | 16.9% |
| 2023-12-31 | 0.05 | 0.23 | -0.19Net Cash | 0.30 | 15.2% |
| 2023-09-30 | 0.05 | 0.18 | -0.13Net Cash | 0.25 | 18.4% |
| 2023-06-30 | 0.05 | 0.20 | -0.16Net Cash | 0.28 | 16.9% |
| 2023-03-31 | 0.05 | 0.23 | -0.19Net Cash | 0.31 | 14.9% |
| 2022-12-31 | 0.05 | 0.26 | -0.22Net Cash | 0.34 | 13.7% |
| 2022-09-30 | 0.05 | 0.27 | -0.23Net Cash | 0.36 | 12.8% |
| 2022-06-30 | 0.05 | 0.29 | -0.25Net Cash | 0.37 | 13.4% |
| 2022-03-31 | 0.01 | 0.32 | -0.31Net Cash | 0.35 | 2.0% |
| 2021-12-31 | 0.00 | 0.35 | -0.35Net Cash | 0.37 | 0.0% |
| 2021-09-30 | 0.00 | 0.37 | -0.37Net Cash | 0.38 | 0.0% |
| 2021-06-30 | 0.00 | 0.36 | -0.36Net Cash | 0.37 | 0.0% |
| 2021-03-31 | 0.23 | 0.17 | 0.06 | 0.18 | 128.0% |
| 2020-12-31 | 0.00 | 0.04 | -0.04Net Cash | 0.05 | 0.0% |
| 2020-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.00 | — |